• (ADM): Archer- Daniels-Midland Upgraded to Buy at Stifel; PT $52
    • (ADS): Alliance Data Downgraded to Neutral at Baird; PT $171
    • (AQN CN): Algonquin Power Downgraded to Hold at Canaccord
    • (CARB): Carbonite Downgraded to Hold at Stifel; PT $25
    • (CPX CN): Capital Power Downgraded to Hold at Canaccord; Price Target C$31
    • (CRSP): Crispr Therapeutics Rated New Buy at BTIG; PT $43
    • (CRSP): Crispr Shares Are a Buy at BTIG as Human Data Expected This Year
    • (EDIT): Editas Rated New Buy at BTIG; PT $30
    • (ENB CN): Enbridge Inc Downgraded to Neutral at UBS; PT Set to C$50
    • (ENLC): EnLink Midstream LLC Rated New Buy at Stifel; PT $13
    • (FCAU): Fiat Chrysler Downgraded to Equal-weight at Barclays
    • (FCAU): Fiat Chrysler Downgraded to Hold at Commerzbank
    • (FTNT): Fortinet Upgraded to Outperform at First Analysis; PT $92
    • (GRUB): GrubHub Upgraded to Buy at Roth Capital; PT $95
    • (IAN CN): iAnthus Capital Rated New Buy at Bryan Garnier
    • (KR): Kroger Rated New Underperform at Buckingham; PT $24
    • (LNR CN): Linamar Downgraded to Neutral at Macquarie; PT C$57
    • (LPG): Dorian LPG Upgraded to Buy at DNB Markets; PT $9.70
    • (MAC): Macerich Downgraded to Market Perform at Wells Fargo; PT $43
    • (MTCH): Match Group Downgraded to Neutral at Nomura Instinet; PT $48
    • (NTLA): Intellia Therapeutics Rated New Buy at BTIG; PT $20
    • (PLAN): Anaplan Downgraded to Equal-weight at Barclays; PT $32
    • (QRVO): Qorvo Downgraded to Hold at Canaccord; PT $70
    • (RARX): Ra Pharmaceuticals Rated New Buy at Stifel; PT $55
    • (RDI): Reading Rated New Outperform at Macquarie; PT $20
    • (RNW CN): TransAlta Renewables Cut to Hold at Canaccord; Price Target C$12
    • (RUF/U CN): Pure Multi-Family REIT Rated New Outperform at BMO; PT $7.15
    • (RYN): Rayonier Upgraded to Market Perform at BMO; Price Target $34
    • (SFM): Sprouts Farmers Rated New Neutral at Buckingham; PT $25
    • (SFS): Smart & Final Rated New Neutral at Buckingham; PT $6.75
    • (SLDB): Solid Biosciences Cut to Market Perform at SVB Leerink; PT $8
    • (SPGI): S&P Global Downgraded to Neutral at UBS
    • (SYNA): Synaptics Downgraded to Neutral at JPMorgan; PT $50
    • (WLTW): Willis Towers Upgraded to Hold at Deutsche Bank; PT Set to $164
    • (WLTW): Willis Towers Earnings Quality Sparks Upgrade at Deutsche Bank